Endocr Pract. 2018 Sep;24(9):833-840. doi: 10.4158/EP-2018-0130.
This article provides suggestions to help clinicians implement important changes in the 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Carcinoma ("ATA 2015") across diverse settings.
Key ATA 2015 changes are summarized regarding: ( 1) thyroid nodule management; ( 2) lobectomy versus thyroidectomy for differentiated thyroid carcinoma (DTC); and ( 3) surveillance following primary treatment of DTC. Advice to facilitate implementation is based on clinical experience and selected literature.
Strategies are described to enhance acquisition of high-quality information that helps identify patients who may possibly avoid fine-needle aspiration (FNA) of thyroid nodules or total thyroidectomy for DTC, or undergo less intense postoperative surveillance. Sonographic imaging of nodules may improve if sonograms are obtained by clinicians ordering or performing FNA or trusted high-volume sonographers. Cytopathologic assessment and reporting can be improved by working with regional or national experts. Pre-operative evaluation by endocrinologists is important so that patients are referred to experienced, proficient surgeons and assisted with well-informed decision-making regarding surgical radicality. Endocrinologists and surgeons should ensure performance of pre-operative neck ultrasonography, voice/laryngeal evaluation, and contrast-enhanced cross-sectional imaging when appropriate. Findings should be disseminated to all healthcare team members, ideally through a comprehensive medical record accessible to the entire team.
Optimization of the sequence of specialist visits and assembly of interactive multidisciplinary teams coupled with intensified interdisciplinary and patient communication may enable clinicians to more effectively implement ATA 2015, which calls for more individualized, and often, less "invasive" management of thyroid nodules and DTC.
ATA 2009 = 2009 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Carcinoma; ATA 2015 = 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Carcinoma; DTC = differentiated thyroid carcinoma; FNA = fine-needle aspiration; PET/CT = positron emission tomography/computed tomography.
本文提供了一些建议,以帮助临床医生在不同环境下实施 2015 年美国甲状腺协会《成人甲状腺结节和分化型甲状腺癌管理指南》(“ATA 2015”)中的重要变革。
总结了 ATA 2015 年的关键变化,包括:(1)甲状腺结节管理;(2)分化型甲状腺癌(DTC)的甲状腺叶切除术与甲状腺全切除术;以及(3)DTC 初始治疗后的监测。实施建议基于临床经验和精选文献。
描述了增强获取高质量信息的策略,以帮助确定可能避免甲状腺结节细针抽吸(FNA)或 DTC 甲状腺全切除术,或接受不那么密集的术后监测的患者。通过进行 FNA 或信任的大容量超声医师的医师或临床医生获取的超声图像,可能会改善结节的超声成像。通过与区域或国家专家合作,可以改善细胞病理学评估和报告。内分泌医师的术前评估很重要,以便将患者转介给经验丰富、熟练的外科医师,并帮助其做出有关手术根治性的明智决策。内分泌医师和外科医师应确保在适当的情况下进行术前颈部超声、声带/喉评估和对比增强横断面成像。最好通过整个团队都可访问的综合医疗记录,将结果传播给所有医疗团队成员。
优化专家就诊顺序,组建互动式多学科团队,加强跨学科和患者沟通,这可能使临床医生能够更有效地实施 ATA 2015,该指南呼吁对甲状腺结节和 DTC 进行更个体化且通常更“微创”的管理。
ATA 2009 = 2009 年美国甲状腺协会《成人甲状腺结节和分化型甲状腺癌管理指南》;ATA 2015 = 2015 年美国甲状腺协会《成人甲状腺结节和分化型甲状腺癌管理指南》;DTC = 分化型甲状腺癌;FNA = 细针抽吸;PET/CT = 正电子发射断层扫描/计算机断层扫描。